Spring Bank Pharmaceuticals, Inc. 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Feb 10, 2017
Insider Transaction Report
Form 4
Freve Jonathan
CFO, Treasurer & Secretary
Transactions
- Award
Stock Option (Right to Buy)
2017-02-09+20,000→ 20,000 totalExercise: $7.66Exp: 2027-02-09→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 9, 2017, with 25% of the shares subject to the option vesting on January 1, 2018 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.